157 related articles for article (PubMed ID: 10818326)
1. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
Fiege M; Wappler F; Scholz J; Weisshorn R; von Richthofen V; Schulte am Esch J
J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine.
Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte Am Esch J
Anesthesiology; 2003 Apr; 98(4):944-9. PubMed ID: 12657857
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.
Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte am Esch J
Eur J Anaesthesiol; 2005 Apr; 22(4):283-8. PubMed ID: 15892406
[TBL] [Abstract][Full Text] [Related]
5. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
[TBL] [Abstract][Full Text] [Related]
6. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].
Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Rumberger E; Löscher W; Schulte am Esch J
Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901
[TBL] [Abstract][Full Text] [Related]
7. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
[TBL] [Abstract][Full Text] [Related]
8. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
[TBL] [Abstract][Full Text] [Related]
9. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
[TBL] [Abstract][Full Text] [Related]
10. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
[TBL] [Abstract][Full Text] [Related]
11. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
[TBL] [Abstract][Full Text] [Related]
12. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.
Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F
Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391
[TBL] [Abstract][Full Text] [Related]
13. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
14. Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
Gilly H; Musat I; Fricker R; Bittner RE; Steinbereithner K; Kress HG
Anesth Analg; 1997 Jul; 85(1):149-54. PubMed ID: 9212139
[TBL] [Abstract][Full Text] [Related]
15. In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.
Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
Anesth Analg; 1996 Jun; 82(6):1230-6. PubMed ID: 8638796
[TBL] [Abstract][Full Text] [Related]
16. Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermia.
Wappler F; Scholz J; Köchling A; Steinfath M; Krause T; Schulte am Esch J
Br J Anaesth; 1997 May; 78(5):541-7. PubMed ID: 9175969
[TBL] [Abstract][Full Text] [Related]
17. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene.
Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Lambrecht W; Schulte am Esch J
Acta Anaesthesiol Scand; 1997 Nov; 41(10):1312-8. PubMed ID: 9422298
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
Mortier W; Breucking E
Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
